CapsoVision, Inc. (CV) investor relations documents from the company's IR site: 1 presentation, 9 press releases; latest deck 2026-08-13. Read in-app with summaries. First-party data.
Corporate Presentation — CapsoVision is a commercial-stage medical technology company developing 360° panoramic capsule endoscopy, reporting $3.6M in Q2 2026 revenue for CapsoCam Plus.
| Published | Type | Document |
|---|---|---|
| 2026-08-13 | Presentation | Corporate Presentation |
| 2026-08-13 | Press release | CapsoVision Reports Second Quarter 2026 Financial Results |
| 2026-08-03 | Press release | CapsoVision® Announces International Launch of AI Highlights |
| 2026-07-30 | Press release | CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026 |
| 2026-07-02 | Press release | CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors |
| 2026-05-14 | Press release | CapsoVision Reports First Quarter 2026 Financial Results |
| 2026-04-30 | Press release | CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 |
| 2026-03-26 | Press release | CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results |
| 2026-03-20 | Press release | CapsoVision Announces $14 Million Private Placement Financing |
| 2026-03-12 | Press release | CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026 |
CV overview · CV earnings · CV financials · CV KPIs · CV ownership · CV peers · CV filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.